Health and Fitness Health and Fitness
Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
OPKO Health Announces Acquisition of Claros Diagnostics
[ Thu, Oct 13th 2011 ] - Market Wire
Cerus to Release Third Quarter 2011 Results on November 1, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
InSite Vision to Present at the Newsmakers in the Biotech Industry Conference
[ Thu, Oct 13th 2011 ] - Market Wire
TheraBiogen, Inc. Begins Record Shipment of Its T .. Cold and Flu Relief to National Drug Store Chains
[ Thu, Oct 13th 2011 ] - Market Wire
Daxor Corporation Announces Signed Trial Agreemen .. iovascular Consultants PLLC in San Antonio, Texas
[ Thu, Oct 13th 2011 ] - Market Wire
Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
High Growth Biotech Firms Zalicus and Sequenom Ready for Knockout Fourth Quarter
[ Thu, Oct 13th 2011 ] - Market Wire
Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off
[ Thu, Oct 13th 2011 ] - Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire
[ Thu, Oct 13th 2011 ] - Market Wire
Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger
[ Thu, Oct 13th 2011 ] - Market Wire
AMRI Appoints New President, India Operations and .. of Project Management a" Pharmaceutical Services
[ Thu, Oct 13th 2011 ] - Market Wire
Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors
[ Thu, Oct 13th 2011 ] - Market Wire
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
[ Thu, Oct 13th 2011 ] - Market Wire
Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL
[ Thu, Oct 13th 2011 ] - Market Wire
POZEN Reports Top-Line Data from Long-Term Safety Study of PA32540
[ Thu, Oct 13th 2011 ] - Market Wire
Galectin Therapeutics to Announce New Data on the Treatment of Fatty Liver Disease and Fibrosis
[ Thu, Oct 13th 2011 ] - Market Wire
U.S. Sales of EGRIFTA(R) Driving Revenue Growth
[ Thu, Oct 13th 2011 ] - Market Wire
Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise
[ Thu, Oct 13th 2011 ] - Market Wire
China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
[ Wed, Oct 12th 2011 ] - Market Wire
Neue Daten, die auf dem 5. gemeinsamen Kongress v .. tellt werden, zeigen neue Forschungsanstze von Bi
[ Wed, Oct 12th 2011 ] - Market Wire
Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
[ Wed, Oct 12th 2011 ] - Market Wire
Savient Pharmaceuticals to Hold Third Quarter 201 .. lts Conference Call on Thursday, November 3, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Helix BioPharma Corp. Files IND Clinical Hold Res .. d Topical Interferon Alpha-2b Phase II/III Effica
[ Wed, Oct 12th 2011 ] - Market Wire
Mylan Announces Intention to Refinance Existing Secured Credit Facility
[ Wed, Oct 12th 2011 ] - Market Wire
Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
[ Wed, Oct 12th 2011 ] - Market Wire
Tornier Announces Conference Call of Third Quarter Results
[ Wed, Oct 12th 2011 ] - Market Wire
The Medicines Company to Announce Third Quarter 2 .. Financial Results on Wednesday, October 26, 2011

The Medicines Company to Announce Third Quarter 2011 Financial Results on Wednesday, October 26, 2011


Published on 2011-10-12 13:35:54 - Market Wire
  Print publication without navigation


October 12, 2011 16:30 ET

The Medicines Company to Announce Third Quarter 2011 Financial Results on Wednesday, October 26, 2011

Conference Call to Be Held at 8:30 a.m. Eastern Time

PARSIPPANY, NJ--(Marketwire - Oct 12, 2011) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled its quarterly conference call for Wednesday, October 26, 2011 at 8:30 a.m. Eastern Time to discuss third quarter 2011 financial results, operational developments, and outlook for 2011.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In: 866-700-7101
International Dial In: 617-213-8837
Passcode for both dial in numbers: 25392199

Replay is available from 11:30 a.m. Eastern Time following the conference call through November 11, 2011. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 31428239.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

About The Medicines Company
The Medicines Company (NASDAQ: [ MDCO ]) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is [ www.themedicinescompany.com ].


Contributing Sources